Why is Morepen Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.02 times
2
With a growth in Net Profit of 57.75%, the company declared Outstanding results in Sep 26
- The company has declared positive results for the last 2 consecutive quarters
- NET SALES(Q) Highest at Rs 746.50 cr
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 254.66 cr
- DEBTORS TURNOVER RATIO(HY) Highest at 6.63 times
3
Stock is technically in a Mildly Bullish range
- Multiple factors for the stock are Bullish like MACD, KST, DOW and OBV
4
With ROE of 13.7, it has a Attractive valuation with a 3.6 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 100.33%, its profits have risen by 150% ; the PEG ratio of the company is 0.2
5
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 2.4% over the previous quarter and collectively hold 5.15% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you buy?
- Overall Portfolio exposure to Morepen Labs. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Morepen Labs. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Morepen Labs.
100.33%
1.61
62.30%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
10.68%
EBIT Growth (5y)
15.50%
EBIT to Interest (avg)
23.01
Debt to EBITDA (avg)
0.60
Net Debt to Equity (avg)
0.04
Sales to Capital Employed (avg)
1.70
Tax Ratio
24.56%
Dividend Payout Ratio
9.29%
Pledged Shares
0
Institutional Holding
5.15%
ROCE (avg)
12.12%
ROE (avg)
9.20%
Valuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
40
Price to Book Value
3.58
EV to EBIT
20.64
EV to EBITDA
18.06
EV to Capital Employed
3.48
EV to Sales
2.18
PEG Ratio
0.17
Dividend Yield
0.22%
ROCE (Latest)
16.88%
ROE (Latest)
13.65%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
35What is working for the Company
NET SALES(Q)
Highest at Rs 746.50 cr
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 254.66 cr
DEBTORS TURNOVER RATIO(HY)
Highest at 6.63 times
PBDIT(Q)
Highest at Rs 123.11 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 16.49%
PBT LESS OI(Q)
Highest at Rs 107.85 cr.
PAT(Q)
Highest at Rs 88.89 cr.
EPS(Q)
Highest at Rs 1.62
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Morepen Labs.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 107.85 cr has Grown at 229.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 32.75 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 88.89 cr has Grown at 203.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 29.33 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 746.50 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 746.50 cr has Grown at 53.1% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 487.65 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 123.11 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 16.49%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 107.85 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 88.89 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 1.62
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 254.66 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Highest at 6.63 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Morepen Labs.
Non Operating Income - Quarterly
Highest at Rs 8.69 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income